Lisa Allyn Boardman

Title: Innovations by Lisa Allyn Boardman

Introduction

Lisa Allyn Boardman is a notable inventor based in Rochester, MN (US). She has made significant contributions to the field of genetics and cancer research, holding two patents that focus on novel human genes and their applications in diagnostics and therapeutics.

Latest Patents

Her latest patents include a method for detecting a differentially expressed sequence. This invention relates to novel human genes, proteins expressed by these genes, and variants of the proteins. It also encompasses diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue. Another patent, titled "Human genes and gene expression products: II," shares similar themes, focusing on novel human genes and their implications in cancer diagnostics and treatment.

Career Highlights

Lisa has worked with prominent organizations such as the Mayo Foundation for Medical Education and Research and Bayer Healthcare LLC. Her work has significantly advanced the understanding of gene expression in cancer, contributing to potential therapeutic strategies.

Collaborations

Some of her notable coworkers include Jon H Astle and Christopher C Burgess. Their collaborative efforts have further enriched the research landscape in which Lisa operates.

Conclusion

Lisa Allyn Boardman's innovative work in genetics and cancer research exemplifies the impact of her inventions on medical science. Her contributions continue to pave the way for advancements in diagnostic and therapeutic approaches.